Today: 20 May 2026
Browse Category

NYSE:BILL 12 November 2025 - 4 January 2026

BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL Holdings shares fell 7.3% to $50.56 Friday, marking one of their steepest single-day drops in weeks. Keefe, Bruyette & Woods raised its price target to $60 but maintained a “market perform” rating. The decline came as the S&P 500 rose 0.19% and the Nasdaq was flat. BILL’s next key events include a Jan. 16 finance leadership change and an earnings update expected in early February.
4 January 2026
··
BILL stock drops about 6% as Wall Street turns choppy to start 2026

BILL stock drops about 6% as Wall Street turns choppy to start 2026

BILL Holdings shares dropped 6.3% to $51.11 in Friday afternoon trading, reversing early gains despite a price-target increase from Keefe, Bruyette & Woods. The stock touched a session low of $50.73 after last closing at $54.54. Investors are awaiting the company’s next quarterly update following its Dec. 31 quarter-end. Broader U.S. markets wobbled as traders rotated into chip stocks.
2 January 2026
·
BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)

BILL Holdings (BILL) Surges as Company Explores a Sale — What Investors Need to Know Today (Nov. 12, 2025)

BILL Holdings shares jumped 13% to $52.68 after reports said the company is exploring a possible sale with help from financial advisers. Talks are in early stages, with no guarantee of a deal. The review follows activist pressure from Starboard Value, which took an 8.5% stake and prompted board changes in October. BILL has not commented on the process.
12 November 2025
··
Stock Market on Edge: U.S. Futures Slide as US-China Trade War Heats Up

5 Stocks to Buy Today (12.11.2025): AMD, On Holding, Cisco, Chevron, BILL

U.S. stock futures rose early Wednesday as investors watched for signs of a federal shutdown resolution and reacted to corporate news. AMD shares climbed pre-market after unveiling aggressive AI revenue targets at its Analyst Day. On Holding raised full-year sales guidance following a strong Q3. Cisco is set to report earnings after the bell. Chevron outlined plans for over 10% annual free cash flow growth through 2030.
12 November 2025
·····

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Go toTop